Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials

YL Deng, XZ Xiong, NS Cheng - Hepatobiliary & Pancreatic Diseases …, 2014 - Elsevier
Background Acute cellular rejection (ACR) after liver transplantation (LT) is one of the most
common problems faced by transplant recipients in spite of advances in immunosuppressive …
被引用次数：6 相关文章

Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials

YL Deng, XZ Xiong, NS Cheng - … & pancreatic diseases …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Acute cellular rejection (ACR) after liver transplantation (LT) is one of the most
common problems faced by transplant recipients in spite of advances in immunosuppressive …

Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials

YL Deng, XZ Xiong, NS Cheng - Hepatobiliary & Pancreatic Diseases …, 2014 - infona.pl
Acute cellular rejection (ACR) after liver transplantation (LT) is one of the most common
problems faced by transplant recipients in spite of advances in immunosuppressive therapy …

Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials.

YL Deng, XZ Xiong, NS Cheng - Hepatobiliary & Pancreatic …, 2014 - europepmc.org
Background Acute cellular rejection (ACR) after liver transplantation (LT) is one of the most
common problems faced by transplant recipients in spite of advances in immunosuppressive …